Straits Times Index
3,336.59 +13.21 (+0.40%) Nikkei
38,487.90 +433.77 (+1.14%) Hang Seng
18,079.61 -150.58 (-0.83%) FTSE 100
8,275.38 +44.33 (+0.54%) Bitcoin USD
67,618.36 +341.25 (+0.51%) CMC Crypto 200
1,423.13 -5.44 (-0.38%)
SWAV Jun 2024 280.000 call
| Previous close | 28.10 |
| Open | 28.10 |
| Bid | 45.10 |
| Ask | 55.00 |
| Strike | 280.00 |
| Expiry date | 2024-06-21 |
| Day's range | 28.10 - 28.10 |
| Contract range | N/A |
| Volume | |
| Open interest | 17 |
Insider MonkeyHere’s Why Shockwave Medical (SWAV) Surged in Q1
Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Mid Cap Growth Fund” first quarter 2024 investor letter. A copy of the letter can be downloaded here. Mid-cap stocks demonstrated strength carried over from the end of last year, delivering robust returns during the first quarter. Among the style indexes, the Russell Midcap Growth […]
PR NewswireSarepta Therapeutics Set to Join S&P MidCap 400
Sarepta Therapeutics Inc. (NASD: SRPT) will replace Shockwave Medical Inc. (NASD: SWAV) in the S&P MidCap 400 effective prior to the opening of trading on Monday, June 3. S&P 500 constituent Johnson & Johnson (NYSE: JNJ) is acquiring Shockwave Medical in a deal expected to be completed soon pending final closing conditions.
ZacksShockwave Medical (SWAV) Q1 Earnings Beat, Revenues Rise Y/Y
Shockwave Medical's (SWAV) first-quarter results reflect robust revenue growth and gross margin expansion amid JNJ entering into a definitive agreement to acquire the company.
